tradingkey.logo

BioNexus Gene Lab Corp

BGLC
2.110USD
+0.120+6.03%
Close 02/06, 16:00ETQuotes delayed by 15 min
3.79MMarket Cap
LossP/E TTM

BioNexus Gene Lab Corp

2.110
+0.120+6.03%

More Details of BioNexus Gene Lab Corp Company

BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.

BioNexus Gene Lab Corp Info

Ticker SymbolBGLC
Company nameBioNexus Gene Lab Corp
IPO dateMar 11, 2020
CEOTan (Lee Su-Leng)
Number of employees30
Security typeOrdinary Share
Fiscal year-endMar 11
Address10-2 Tower B, Vertical Business Suite
CityKUALA LUMPUR
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryMalaysia
Postal code59200
Phone13072416898
Websitehttps://www.bionexusgenelab.com/
Ticker SymbolBGLC
IPO dateMar 11, 2020
CEOTan (Lee Su-Leng)

Company Executives of BioNexus Gene Lab Corp

Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-1.00%
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--
Ms. Meng Wong Yee
Ms. Meng Wong Yee
Director
Director
--
--
Ms. Hua Yew Chak
Ms. Hua Yew Chak
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Teong Teoh Boon
Mr. Teong Teoh Boon
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Ping Lin Chai
Mr. Ping Lin Chai
Independent Non-Executive Director
Independent Non-Executive Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Ms. Jook Yuen Low
Ms. Jook Yuen Low
Independent Director
Independent Director
1.26K
-1.00%
Mr. Chi Yuen (George) Leong
Mr. Chi Yuen (George) Leong
Director
Director
--
--
Mr. Teng Fook Fong
Mr. Teng Fook Fong
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Chee Keong Yap
Mr. Chee Keong Yap
Independent Non-Executive Director
Independent Non-Executive Director
--
--
Mr. Lee Su-Leng Tan
Mr. Lee Su-Leng Tan
President, Chief Executive Officer, Chief Operating Officer
President, Chief Executive Officer, Chief Operating Officer
--
--
Mr. Min Fong Yeat
Mr. Min Fong Yeat
Chairman of the Board
Chairman of the Board
--
--

Revenue Breakdown

Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Other
63.04%
Shareholders
Shareholders
Proportion
Fidelion Diagnostics Pte Ltd
16.60%
ARC Group Ltd
7.40%
Liew (Choong-Chin)
7.05%
Lai (Soo Kow(kenny))
5.29%
DRW Securities, LLC
0.62%
Other
63.04%
Shareholder Types
Shareholders
Proportion
Corporation
24.00%
Individual Investor
12.39%
Investment Advisor
0.62%
Investment Advisor/Hedge Fund
0.10%
Other
62.89%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
14
22.28K
1.52%
--
2025Q3
14
22.28K
2.00%
+12.71K
2025Q2
13
9.56K
1.47%
-6.24K
2025Q1
13
15.80K
1.33%
-8.09K
2024Q4
12
17.81K
1.26%
+4.78K
2024Q3
9
13.03K
0.67%
+6.46K
2024Q2
7
6.57K
0.88%
-3.53K
2024Q1
7
10.10K
0.59%
-313.00
2023Q4
6
10.42K
1.15%
-9.94K
2023Q3
5
20.36K
0.00%
+20.36K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Fidelion Diagnostics Pte Ltd
392.33K
16.6%
+392.33K
--
Nov 28, 2025
ARC Group Ltd
175.00K
7.4%
+175.00K
--
Nov 28, 2025
Liew (Choong-Chin)
166.67K
7.05%
-1.00
-0.00%
Nov 28, 2025
Lai (Soo Kow(kenny))
125.00K
5.29%
-1.00
-0.00%
Nov 28, 2025
DRW Securities, LLC
14.65K
0.62%
+14.65K
--
Sep 30, 2025
Geode Capital Management, L.L.C.
--
0%
-2.37K
-100.00%
Jun 30, 2025
Low (Jook Yuen)
1.26K
0.05%
-1.00
-0.08%
Nov 28, 2025
Blackstone Alternative Investment Advisors LLC
3.00
0%
--
--
Jun 30, 2025
Scientech Research LLC
--
0%
-1.08K
-100.00%
Mar 31, 2025
XTX Markets LLC
--
0%
-3.28K
-100.00%
Mar 31, 2025
View more

Related ETFs

Name
Proportion
No Data

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
Apr 03, 2025
Merger
10→1
Date
Ex-dividend Date
Type
Ratio
Apr 03, 2025
Merger
10→1
KeyAI